Karen A Miotto

Title(s)Professor Of Clinical, Psychiatry and Biobehavioral Sciences
SchoolMedicine
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    GHB: Effects, Withdrawal and Treatment
    NIH K23DA014291Sep 30, 2002 - Aug 31, 2008
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. A practice quit model to test early efficacy of medications for alcohol use disorder in a randomized clinical trial. Psychopharmacology (Berl). 2024 Mar; 241(3):543-553. Ray LA, Baskerville WA, Nieto SJ, Grodin E, Enders C, Kady A, Meredith L, Gillis A, Leventhal A, Ho D, Miotto K. PMID: 38012333; PMCID: PMC11927384.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    2. Before and During the First COVID-19 Surge: Work Conditions, Burnout, and Mental Health Among Resident Physicians in a Department of Psychiatry in the USA. Acad Psychiatry. 2023 Oct; 47(5):504-509. Agrawal A, De La Torre K, Cooper C, Flores J, Miotto K, Wells K, Bromley E, Yano EM, Heldt J, Castillo EG, DeBonis K. PMID: 37634240; PMCID: PMC10602943.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    3. Baseline C-reactive protein levels are predictive of treatment response to a neuroimmune modulator in individuals with an alcohol use disorder: a preliminary study. Am J Drug Alcohol Abuse. 2023 05 04; 49(3):333-344. Grodin EN, Meredith LR, Burnette EM, Miotto K, Irwin MR, Ray LA. PMID: 36282988; PMCID: PMC10840759.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    4. Effects of ibudilast on central and peripheral markers of inflammation in alcohol use disorder: A randomized clinical trial. Addict Biol. 2022 07; 27(4):e13182. Grodin EN, Nieto SJ, Meredith LR, Burnette E, O'Neill J, Alger J, London ED, Miotto K, Evans CJ, Irwin MR, Ray LA. PMID: 35754106; PMCID: PMC9888600.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimals
    5. Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder. Drugs. 2022 Feb; 82(3):251-274. Burnette EM, Nieto SJ, Grodin EN, Meredith LR, Hurley B, Miotto K, Gillis AJ, Ray LA. PMID: 35133639; PMCID: PMC8888464.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    6. Combined varenicline and naltrexone attenuates alcohol cue-elicited activation in heavy drinking smokers. Drug Alcohol Depend. 2021 08 01; 225:108825. Grodin EN, Burnette EM, Green R, Lim AC, Miotto K, Ray LA. PMID: 34175784; PMCID: PMC9059649.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    7. Ibudilast, a neuroimmune modulator, reduces heavy drinking and alcohol cue-elicited neural activation: a randomized trial. Transl Psychiatry. 2021 06 12; 11(1):355. Grodin EN, Bujarski S, Towns B, Burnette E, Nieto S, Lim A, Lin J, Miotto K, Gillis A, Irwin MR, Evans C, Ray LA. PMID: 34120149; PMCID: PMC8197758.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    8. Efficacy of Combining Varenicline and Naltrexone for Smoking Cessation and Drinking Reduction: A Randomized Clinical Trial. Am J Psychiatry. 2021 09 01; 178(9):818-828. Ray LA, Green R, Enders C, Leventhal AM, Grodin EN, Li G, Lim A, Hartwell E, Venegas A, Meredith L, Nieto SJ, Shoptaw S, Ho D, Miotto K. PMID: 34080890; PMCID: PMC8999864.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    9. Psychological Distress Among Women Healthcare Workers: A Health System's Experience Developing Emotional Support Services During the COVID-19 Pandemic. Front Glob Womens Health. 2021; 2:614723. Sanford J, Agrawal A, Miotto K. PMID: 34816185; PMCID: PMC8593987.
      View in: PubMed   Mentions: 8  
    10. Implementing an emotional support and mental health response plan for healthcare workers during the COVID-19 pandemic. Psychol Trauma. 2020 Aug; 12(S1):S165-S167. Miotto K, Sanford J, Brymer MJ, Bursch B, Pynoos RS. PMID: 32525378.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansPHPublic Health
    11. Outcomes of Physicians with Substance Use Disorders in State Physician Health Programs: A Narrative Review. J Psychoactive Drugs. 2020 Jul-Aug; 52(3):195-202. Goldenberg M, Miotto K, Skipper GE, Sanford J. PMID: 32156222.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    12. Neuroimaging findings from an experimental pharmacology trial of naltrexone in heavy drinkers of East Asian descent. Drug Alcohol Depend. 2019 07 01; 200:181-190. Lim AC, Ghahremani DG, Grodin EN, Green R, Bujarski S, Hartwell EE, Courtney KE, Hutchison K, Miotto K, Ray LA. PMID: 31160146; PMCID: PMC6760244.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    13. Escalating Opioid Dose Is Associated With Mortality: A Comparison of Patients With and Without Opioid Use Disorder. J Addict Med. 2019 Jan/Feb; 13(1):41-46. Hser YI, Saxon AJ, Mooney LJ, Miotto K, Zhu Y, Yoo CK, Liang D, Huang D, Bell DS. PMID: 30418260; PMCID: PMC6349485.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    14. State-of-the-art behavioral and pharmacological treatments for alcohol use disorder. Am J Drug Alcohol Abuse. 2019; 45(2):124-140. Ray LA, Bujarski S, Grodin E, Hartwell E, Green R, Venegas A, Lim AC, Gillis A, Miotto K. PMID: 30373394; PMCID: PMC6430676.
      View in: PubMed   Mentions: 69     Fields:    Translation:Humans
    15. Differences in the subjective and motivational properties of alcohol across alcohol use severity: application of a novel translational human laboratory paradigm. Neuropsychopharmacology. 2018 08; 43(9):1891-1899. Bujarski S, Jentsch JD, Roche DJO, Ramchandani VA, Miotto K, Ray LA. PMID: 29802367; PMCID: PMC6046045.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    16. Adaptation and Evaluation of Military Resilience Skills Training for Pediatric Residents. J Med Educ Curric Dev. 2017 Jan-Dec; 4:2382120517741298. Bursch B, Lloyd J, Mogil C, Wijesekera K, Miotto K, Wu M, Wilkinson R, Klomhaus A, Iverson A, Lester P. PMID: 29349344; PMCID: PMC5736280.
      View in: PubMed   Mentions: 3  
    17. High Mortality Among Patients With Opioid Use Disorder in a Large Healthcare System. J Addict Med. 2017 Jul/Aug; 11(4):315-319. Hser YI, Mooney LJ, Saxon AJ, Miotto K, Bell DS, Zhu Y, Liang D, Huang D. PMID: 28426439; PMCID: PMC5930020.
      View in: PubMed   Mentions: 70     Fields:    
    18. Chronic pain among patients with opioid use disorder: Results from electronic health records data. J Subst Abuse Treat. 2017 06; 77:26-30. Hser YI, Mooney LJ, Saxon AJ, Miotto K, Bell DS, Huang D. PMID: 28476267; PMCID: PMC5424616.
      View in: PubMed   Mentions: 90     Fields:    Translation:Humans
    19. Development of the Neuroimmune Modulator Ibudilast for the Treatment of Alcoholism: A Randomized, Placebo-Controlled, Human Laboratory Trial. Neuropsychopharmacology. 2017 Aug; 42(9):1776-1788. Ray LA, Bujarski S, Shoptaw S, Roche DJ, Heinzerling K, Miotto K. PMID: 28091532; PMCID: PMC5520778.
      View in: PubMed   Mentions: 64     Fields:    Translation:Humans
    20. Trends in Tramadol: Pharmacology, Metabolism, and Misuse. Anesth Analg. 2017 01; 124(1):44-51. Miotto K, Cho AK, Khalil MA, Blanco K, Sasaki JD, Rawson R. PMID: 27861439.
      View in: PubMed   Mentions: 102     Fields:    Translation:HumansAnimals
    21. A Call to Action: The Active Role Psychiatrists and the DEA Must Take to Decrease Harm from Psychotropic Drugs Acquired via the Internet. J Clin Psychiatry. 2016 11; 77(11):e1495. Goldenberg M, Hassamal S, IsHak WW, Haglund M, Miotto K, Danovitch I. PMID: 28076677.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    22. A narrative review: The effects of opioids on sleep disordered breathing in chronic pain patients and methadone maintained patients. Am J Addict. 2016 09; 25(6):452-65. Hassamal S, Miotto K, Wang T, Saxon AJ. PMID: 27554389.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    23. The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study. Neuropsychopharmacology. 2015 Sep; 40(10):2347-56. Ray LA, Bujarski S, Courtney KE, Moallem NR, Lunny K, Roche D, Leventhal AM, Shoptaw S, Heinzerling K, London ED, Miotto K. PMID: 25801501; PMCID: PMC4538349.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    24. Varenicline, low dose naltrexone, and their combination for heavy-drinking smokers: human laboratory findings. Psychopharmacology (Berl). 2014 Oct; 231(19):3843-53. Ray LA, Courtney KE, Ghahremani DG, Miotto K, Brody A, London ED. PMID: 24733235; PMCID: PMC4161630.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    25. Clinical and pharmacological aspects of bath salt use: a review of the literature and case reports. Drug Alcohol Depend. 2013 Sep 01; 132(1-2):1-12. Miotto K, Striebel J, Cho AK, Wang C. PMID: 23916320.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansAnimals
    26. Primary care management of opioid dependence: the addition of CBT gives no extra benefit compared to standard physician management alone. Evid Based Ment Health. 2013 Aug; 16(3):76. Miotto K. PMID: 23616210.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    27. Subjective response to alcohol among alcohol-dependent individuals: effects of the μ-opioid receptor (OPRM1) gene and alcoholism severity. Alcohol Clin Exp Res. 2013 Jan; 37 Suppl 1:E116-24. Ray LA, Bujarski S, MacKillop J, Courtney KE, Monti PM, Miotto K. PMID: 23240711; PMCID: PMC3548029.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    28. Comparisons of analgesic potency and side effects of buprenorphine and buprenorphine with ultra-low-dose naloxone. J Addict Med. 2012 Jun; 6(2):118-23. Ling W, Hillhouse M, Jenkins J, Miotto K, Torrington M, Chapleo C. PMID: 22475985.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    29. Managing co-occurring substance use and pain disorders. Psychiatr Clin North Am. 2012 Jun; 35(2):393-409. Miotto K, Kaufman A, Kong A, Jun G, Schwartz J. PMID: 22640762.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    30. Comparison of buprenorphine treatment for opioid dependence in 3 settings. J Addict Med. 2012 Mar; 6(1):68-76. Miotto K, Hillhouse M, Donovick R, Cunningham-Rathner J, Charuvastra C, Torrington M, Esagoff AE, Ling W. PMID: 22105061; PMCID: PMC3276753.
      View in: PubMed   Mentions: 18     Fields:    
    31. Selective review and commentary on emerging pharmacotherapies for opioid addiction. Subst Abuse Rehabil. 2011; 2:181-8. Ling W, Mooney L, Zhao M, Nielsen S, Torrington M, Miotto K. PMID: 24474855; PMCID: PMC3846315.
      View in: PubMed   Mentions: 4  
    32. Pharmacogenetics of naltrexone in asian americans: a randomized placebo-controlled laboratory study. Neuropsychopharmacology. 2012 Jan; 37(2):445-55. Ray LA, Bujarski S, Chin PF, Miotto K. PMID: 21900886; PMCID: PMC3242306.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    33. A human laboratory study of the effects of quetiapine on subjective intoxication and alcohol craving. Psychopharmacology (Berl). 2011 Oct; 217(3):341-51. Ray LA, Chin PF, Heydari A, Miotto K. PMID: 21487653.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    34. Elevated plasma prolactin in abstinent methamphetamine-dependent subjects. Am J Drug Alcohol Abuse. 2011 Jan; 37(1):62-7. Zorick T, Mandelkern MA, Lee B, Wong ML, Miotto K, Shabazian J, London ED. PMID: 21142706; PMCID: PMC3056536.
      View in: PubMed   Mentions: 2     Fields:    
    35. Withdrawal symptoms in abstinent methamphetamine-dependent subjects. Addiction. 2010 Oct; 105(10):1809-18. Zorick T, Nestor L, Miotto K, Sugar C, Hellemann G, Scanlon G, Rawson R, London ED. PMID: 20840201; PMCID: PMC3071736.
      View in: PubMed   Mentions: 80     Fields:    
    36. Naltrexone for the treatment of alcoholism: clinical findings, mechanisms of action, and pharmacogenetics. CNS Neurol Disord Drug Targets. 2010 Mar; 9(1):13-22. Ray LA, Chin PF, Miotto K. PMID: 20201811.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    37. Opioid pharmaceuticals and addiction: the issues, and research directions seeking solutions. Drug Alcohol Depend. 2010 May 01; 108(3):156-65. Walwyn WM, Miotto KA, Evans CJ. PMID: 20188495; PMCID: PMC3072810.
      View in: PubMed   Mentions: 20     Fields:    
    38. Pilot safety evaluation of varenicline for the treatment of methamphetamine dependence. J Exp Pharmacol. 2010; 2:13-8. Zorick T, Sevak RJ, Miotto K, Shoptaw S, Swanson AN, Clement C, De La Garza R, Newton TF, London ED. PMID: 27186086; PMCID: PMC2915574.
      View in: PubMed   Mentions: 8  
    39. Urine and plasma pharmacokinetics of lofexidine after oral delivery in opiate-dependent patients. Am J Drug Alcohol Abuse. 2009; 35(5):311-5. Al Ghananeem AM, Herman BH, Abbassi M, Yu E, Miotto K, O'Brien CP, Ling W, Montgomery A, Walsh R. PMID: 19637105.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    40. A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal. Drug Alcohol Depend. 2008 Sep 01; 97(1-2):158-68. Yu E, Miotto K, Akerele E, Montgomery A, Elkashef A, Walsh R, Montoya I, Fischman MW, Collins J, McSherry F, Boardman K, Davies DK, O'Brien CP, Ling W, Kleber H, Herman BH. PMID: 18508207; PMCID: PMC2613766.
      View in: PubMed   Mentions: 24     Fields:    Translation:CTClinical Trials
    41. Clinical pharmacokinetics of lofexidine, the alpha 2-adrenergic receptor agonist, in opiate addicts plasma using a highly sensitive liquid chromatography tandem mass spectrometric analysis. Am J Drug Alcohol Abuse. 2008; 34(5):611-6. Yu E, Miotto K, Akerele E, O'Brien CP, Ling W, Kleber H, Fischman MW, Elkashef A, Herman BH, Al-Ghananeem AM. PMID: 18821454.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    42. A comparison of contingency management and cognitive-behavioral approaches for stimulant-dependent individuals. Addiction. 2006 Feb; 101(2):267-74. Rawson RA, McCann MJ, Flammino F, Shoptaw S, Miotto K, Reiber C, Ling W. PMID: 16445555.
      View in: PubMed   Mentions: 90     Fields:    Translation:Humans
    43. Precipitated opioid withdrawal across acute physical dependence induction methods. Pharmacol Biochem Behav. 2004 Feb; 77(2):263-8. Compton P, Miotto K, Elashoff D. PMID: 14751453.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    44. Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Arch Gen Psychiatry. 2004 Jan; 61(1):73-84. London ED, Simon SL, Berman SM, Mandelkern MA, Lichtman AM, Bramen J, Shinn AK, Miotto K, Learn J, Dong Y, Matochik JA, Kurian V, Newton T, Woods R, Rawson R, Ling W. PMID: 14706946.
      View in: PubMed   Mentions: 129     Fields:    Translation:Humans
    45. The effects and consequences of selected club drugs. J Subst Abuse Treat. 2002 Sep; 23(2):151-6. Freese TE, Miotto K, Reback CJ. PMID: 12220613.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    46. Naltrexone and dysphoria: fact or myth? Am J Addict. 2002; 11(2):151-60. Miotto K, McCann M, Basch J, Rawson R, Ling W. PMID: 12028745.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    47. Gamma-hydroxybutyric acid: patterns of use, effects and withdrawal. Am J Addict. 2001; 10(3):232-41. Miotto K, Darakjian J, Basch J, Murray S, Zogg J, Rawson R. PMID: 11579621.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    Karen's Networks
    Concepts (203)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (25)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-15-g9ae42700 on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California